Last updated on November 2017

Adults 18 and older with primary insomnia.

Brief description of study

Adults 18 and older with primary insomnia.

Detailed Study Description

A double-blind randomized, placebo-controlled, 30 night polysomnographic study of an investigational medication in adults 18 and older with primary insomnia.

To qualify, you must be:

  • 18 years and older

Length of study: 6 weeks
Overnight visits: 10
Total number of outpatient visits: 1

For more information,

Clinical Study Identifier: TX232

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.